Karl S. Theil

4.9k citations

73 papers · 3.6k indexed · 1 hit paper · h-index 27

Hematology top 0.2%
Molecular Biology top 10%
Genetics top 1%
Public Health, Environmental and Occupational Health top 2%
Oncology top 10%

Co-authors: Anwar N. Mohamed Kenneth J. Kopecky Frederick R. Appelbaum Marilyn L. Slovak David R. Head Stephen J. Forman Peter A. Cassileth Cheryl L. Willman
Topics: Acute Myeloid Leukemia Research (28 papers)Acute Lymphoblastic Leukemia research (16 papers)Chronic Myeloid Leukemia Treatments (11 papers)
Cited by: Hematology Genetics Public Health, Environmental and Occupational Health
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Blood
Partner nations: United States South Korea Switzerland

In The Last Decade

Karl S. Theil

72 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

2000 1.2k citations Marilyn L. Slovak, Karl S. Theil et al. Blood profile →

Peers

Countries citing papers authored by Karl S. Theil

Since Specialization

Citations

This map shows the geographic impact of Karl S. Theil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl S. Theil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl S. Theil more than expected).

Fields of papers citing papers by Karl S. Theil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl S. Theil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl S. Theil. The network helps show where Karl S. Theil may publish in the future.

Co-authorship network of co-authors of Karl S. Theil

This figure shows the co-authorship network connecting the top 25 collaborators of Karl S. Theil. A scholar is included among the top collaborators of Karl S. Theil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl S. Theil. Karl S. Theil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia) 2022 ·Advances in Hematology ·Maroun Bou Zerdan,Jason Valent,Maria Julia Diacovo,Karl S. Theil,Chakra P. Chaulagain	6
2	Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations 2016 ·Journal of Clinical Pathology ·(unknown),Gurunathan Murugesan,Claudiu Cotta,Karl S. Theil	5
3	The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors 2014 ·Cancer Genetics ·Karl S. Theil,Claudiu Cotta	2
4	Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities 2011 ·Blood ·Samar Farha,Kewal Asosingh,Weiling Xu,Jacqueline Sharp,Deepa George,Suzy Comhair,Margaret Park,W.H. Wilson Tang,James E. Loyd,Karl S. Theil,Raymond Tubbs,Eric D. Hsi,Alan Lichtin,Serpil C. Erzurum	107
5	Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis 2011 ·Molecular Cytogenetics ·Kathryn A. Kolquist,Roger A. Schultz,Marilyn L. Slovak,Lisa D. McDaniel,Theresa C. Brown,Raymond R. Tubbs,James R. Cook,Karl S. Theil,(unknown),(unknown),(unknown),Nicholas J. Neill,(unknown),(unknown),Trilochan Sahoo,Blake C. Ballif,Lisa G. Shaffer	10
6	College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis 2011 ·Genetics in Medicine ·Arthur R. Brothman,Michelle Dolan,Barbara K. Goodman,Jonathan P. Park,Diane L. Persons,Debra Saxe,James Tepperberg,Karen D. Tsuchiya,Daniel L. Van Dyke,Kathleen Wilson,Daynna J. Wolff,Karl S. Theil	12
7	FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q) 2009 ·Leukemia Research ·Hideki Makishima,(unknown),Lukasz P. Gondek,Jungwon Huh,James R. Cook,Karl S. Theil,Mikkael A. Sekeres,(unknown),Christine L. O’Keefe,Jaroslaw P. Maciejewski	53
8	A rare trigger for macrophage activation syndrome 2009 ·Rheumatology International ·Shikhar Agarwal,(unknown),(unknown),Karl S. Theil,Syed Mahmood,Richard Lang	24
9	Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation 2008 ·Bone Marrow Transplantation ·Ronald Sobecks,Edward J. Ball,Medhat Askar,Karl S. Theil,Lisa Rybicki,Dawn Thomas,Stacey Brown,M Kalaycio,Steve Andresen,Brad Pohlman,Robert M. Dean,John Sweetenham,Roger M. Macklis,(unknown),(unknown),Edward A. Copelan,J. Maciejewski,Brian J. Bolwell	13
10	400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation 2008 ·Bone Marrow Transplantation ·Ronald Sobecks,Robert M. Dean,Lisa Rybicki,Jonathan Chan,Karl S. Theil,Roger M. Macklis,Steve Andresen,M Kalaycio,Brad Pohlman,(unknown),(unknown),John Sweetenham,Edward A. Copelan,Brian J. Bolwell	7
11	Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia 2008 ·Leukemia & lymphoma ·Anjali S. Advani,Tao Jin,Giridharan Ramsingh,Ramón V. Tiu,Wael Saber,Karl S. Theil,Ronald Sobecks,Mikkael A. Sekeres,Ed Copelan,(unknown),(unknown),Matt Kalaycio	4
12	High-Resolution Genomic Arrays Facilitate Detection of Novel Cryptic Chromosomal Lesions in Myelodysplastic Syndromes 2007 ·Experimental Hematology ·Christine L. O’Keefe,Ramón V. Tiu,Lukasz P. Gondek,Jennifer Powers,Karl S. Theil,Matt Kalaycio,Alan Lichtin,Mikkael A. Sekeres,Jaroslaw P. Maciejewski	24
13	Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution 2006 ·Cancer Genetics and Cytogenetics ·Jin‐Yeong Han,Karl S. Theil,Gerald A. Hoeltge	13
14	Efficient identification of T‐cell clones associated with graft‐versus‐host disease in target tissue allows for subsequent detection in peripheral blood 2005 ·British Journal of Haematology ·Rose Beck,Marcin W. Włodarski,Lukasz P. Gondek,Karl S. Theil,Ralph J. Tuthill,(unknown),Brian J. Bolwell,Jaroslaw P. Maciejewski	21
15	Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone 2003 ·Bone Marrow Transplantation ·Brian J. Bolwell,Ronald Sobecks,Brad Pohlman,Steve Andresen,Karl S. Theil,(unknown),Lisa Rybicki,M Kalaycio	6
16	Detection of Mature T-Cell Leukemias by Flow Cytometry Using Anti-T-Cell Receptor V b Antibodies 2003 ·American Journal of Clinical Pathology ·Rose Beck,(unknown),Christine L. O’Keefe,Jaroslaw P. Maciejewski,Karl S. Theil,Eric D. Hsi	46
17	Localization of FCGR1 encoding Fcγ receptor class I in primates: molecular evidence for two pericentric inversions during the evolution of human chromosome 1 1998 ·Cytogenetic and Genome Research ·(unknown),(unknown),(unknown),Robert P. Kimberly,Clark L. Anderson,Karl S. Theil	17
18	The three genes of the human FCGR1 gene family encoding FcγRI flank the centromere of chromosome 1 at 1p12 and 1q21 1996 ·Cytogenetic and Genome Research ·(unknown),(unknown),Karl S. Theil,Uta Francke,Clark L. Anderson	28
19	Characterization of the 5q‐ breakpoint in an acute nonlymphocytic leukemia patient using pulsed‐field gel electrophoresis 1991 ·American Journal of Medical Genetics ·Donald Thornton,Karl S. Theil,(unknown),Stanley P. Balcerzak,Ing‐Ming Chiu	7
20	Hairy Cell Leukemia Involving an Inguinal Hernial Sac 1990 ·Acta Haematologica ·(unknown),Karl S. Theil,W. Marsh,Daniel D. Sedmak,Bertha A. Bouroncle	8

About Karl S. Theil

Karl S. Theil is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (11 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (903 citations) and Public Health, Environmental and Occupational Health (798 citations). Karl S. Theil has collaborated with scholars based in United States, South Korea and Switzerland. Frequent co-authors include Anwar N. Mohamed, Kenneth J. Kopecky, Frederick R. Appelbaum, Marilyn L. Slovak, David R. Head, Stephen J. Forman, Peter A. Cassileth, Cheryl L. Willman, Jacob M. Rowe and David H. Harrington. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact